All Relations between asymmetrical (pato 0000616) and nitrogen monoxide

Reference Sentence Publish Date Extraction Date Species
Yukiko K Kaneko, Ami Morioka, Misaki Sano, Maho Tashiro, Naoya Watanabe, Nahoko Kasahara, Masato Nojiri, Chihiro Ishiwatari, Kentaro Ichinose, Akira Minami, Takashi Suzuki, Momoka Yamaguchi, Toshihide Kimura, Tomohisa Ishikaw. Asymmetric dimethylarginine accumulation under hyperglycemia facilitates \\xce\\xb2-cell apoptosis via inhibiting nitric oxide production. Biochemical and biophysical research communications vol 637 issue 2022 36395692 asymmetric dimethylarginine accumulation under hyperglycemia facilitates \xce\xb2-cell apoptosis via inhibiting nitric oxide production. 2022-11-17 2022-11-21 Not clear
Eleni Pagkopoulou, Stergios Soulaidopoulos, Eva Triantafyllidou, Charalampos Loutradis, Afrodite Malliari, George D Kitas, Alexandros Garyfallos, Theodoros Dimitroula. Asymmetric dimethylarginine correlates with worsening peripheral microangiopathy in systemic sclerosis. Microvascular research vol 145 issue 2022 36374797 asymmetric dimethylarginine (adma) is an endogenous nitric oxide (no) inhibitor and represents a novel biomarker for vascular dysfunction. 2022-11-14 2022-11-15 Not clear
Michalina Jezierska, Joanna Stefanowic. Asymmetric and Symmetric Dimethylarginines as Renal Function Parameters in Paediatric Kidney Diseases: A Literature Review from 2003 to 2022. Children (Basel, Switzerland) vol 9 issue 11 2022 36360396 asymmetric dimethylarginine (adma) and symmetric dimethylarginine (sdma), inhibitors of nitric oxide synthase, play important roles in many processes in the body. 2022-11-11 2022-11-15 Not clear
Paulina Wo\\xc5\\x82oszyk-Chojecka, Sylwia Malgorzewicz, Andrzej Chamienia, Ewelina Puchalska-Regli\\xc5\\x84ska, Alicja D\\xc4\\x99bska-\\xc5\\x9alizie\\xc5\\x8. Prevalence of cardiovascular diseases in kidney transplant recipients and its relationship with asymmetric dimethylarginine, fibroblast growth factor-23 and multiple inflammatory markers. Acta biochimica Polonica vol issue 2022 36346961 asymmetric dimethylarginine (adma) is an endogenous inhibitor of endothelial nitric oxide synthase, a marker of endothelial damage and progression of atherosclerosis. 2022-11-08 2022-11-15 Not clear
Wei-Jin Fang, Xiao-Mei Li, Xin-Ke Zhou, Yan Xion. Resveratrol improves diabetic cardiomyopathy by preventing asymmetric dimethylarginine-caused peroxisome proliferator-activated receptor-\\xce\\xb3 coactivator-1\\xce\\xb1 acetylation. European journal of pharmacology vol 936 issue 2022 36341883 asymmetric dimethylarginine (adma) as an endogenous inhibitor of nitric oxide synthases is associated with diabetic cardiovascular complications and has a cross-talk with lysine acetylation. 2022-11-07 2022-11-08 Not clear
Tianhe Li, Tingting Zhang, Huanhuan Wang, Qiaoli Zhang, Huimin Gao, Ruixia Liu, Chenghong Yi. The ADMA-DDAH1 axis in ovarian apoptosis of polycystic ovary syndrome. The Journal of steroid biochemistry and molecular biology vol issue 2022 36243205 dimethylarginine dimethylaminohydrolase 1 (ddah1) mainly degrades asymmetric dimethylarginine (adma), an endogenous nitric oxide synthase inhibitor. 2022-10-15 2022-10-25 Not clear
Abdullah Erdogan, Ercument Keskin, Murat Sambel, Cuma Mertogl. Assessing the nitric oxide and asymmetric dimethylarginine levels in lifelong premature ejaculation: A prospective study. Revista internacional de andrologia vol issue 2022 35907768 assessing the nitric oxide and asymmetric dimethylarginine levels in lifelong premature ejaculation: a prospective study. 2022-07-30 2022-08-08 Not clear
Abdullah Erdogan, Ercument Keskin, Murat Sambel, Cuma Mertogl. Assessing the nitric oxide and asymmetric dimethylarginine levels in lifelong premature ejaculation: A prospective study. Revista internacional de andrologia vol issue 2022 35907768 to evaluate nitric oxide (no) and asymmetric dimethylarginine (adma) levels in men with premature ejaculation (pe), which is a common condition that adversely affects quality of life. 2022-07-30 2022-08-08 Not clear
Chun-Fan Chen, Chiu-Yang Lee, Fu-An Chen, Chih-Yu Yang, Tz-Heng Chen, Shuo-Ming Ou, Kuo-Hua Lee, Ching-Po Li, Chia-Hao Chan, Pui-Ching Lee, Yung-Tai Chen, Tsung-Lun Lee, Yang Ho, Fan-Yu Chen, Hao-Wei Ma, Jinn-Yang Chen, Ann Charis Tan, Szu-Yuan Li, Chih-Ching Li. Far-Infrared Therapy Improves Arteriovenous Fistula Patency and Decreases Plasma Asymmetric Dimethylarginine in Patients with Advanced Diabetic Kidney Disease: A Prospective Randomized Controlled Trial. Journal of clinical medicine vol 11 issue 14 2022 35887935 asymmetric dimethylarginine (adma) is an endogenous inhibitor of nitric oxide synthase and plays a significant role in the pathogenesis of arteriovenous fistula (avf) dysfunction. 2022-07-27 2022-08-08 Not clear
Kun Fang, Shufen Chen, Yi Wang, Fangzhe Chen, Mei Cui, Qiang Don. Asymmetric Dimethylarginine Protects Neurons from Oxygen Glucose Deprivation Insult by Modulating Connexin-36 Expression. Oxidative medicine and cellular longevity vol 2022 issue 2022 35847590 asymmetric dimethylarginine (adma) is a nonselective nitric oxide synthase inhibitor. 2022-07-18 2022-07-19 Not clear
Shumpei Fujie, Kiyoshi Sanada, Takafumi Hamaoka, Motoyuki Iemits. Time-dependent relationships between exercise training-induced changes in nitric oxide production and hormone regulation. Experimental gerontology vol issue 2022 35820510 aerobic exercise training (at) reduces aging-induced deterioration of arterial stiffness and is associated with arterial nitric oxide (no) production via changes in apelin and adropin as no-upregulating hormones, and asymmetric dimethylarginine (adma) as a no-downregulating hormone. 2022-07-12 2022-07-19 Not clear
Wiebe M C Top, Philippe Lehert, Casper G Schalkwijk, Coen D A Stehouwer, Adriaan Koo. Effect of metformin on arginine and dimethylarginines in patients with advanced type 2 diabetes: A post hoc analysis of a randomized trial. Diabetes, obesity & metabolism vol issue 2022 35789192 to study the effect of metformin on plasma levels of arginine, asymmetric dimethylarginine (adma) and symmetric dimethylarginine (sdma), indicators of the nitric oxide pathway. 2022-07-05 2022-07-07 Not clear
Yasmin T Mohamed, Ibrahim A Naguib, Ali A Abo-Saif, Mohammed H Elkomy, Badrah S Alghamdi, Wafaa R Mohame. Role of ADMA/DDAH-1 and iNOS/eNOS signaling in the gastroprotective effect of tadalafil against indomethacin-induced gastric injury. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol 150 issue 2022 35658250 inducible nitric oxide synthase/endothelial nitric oxide synthase (inos/enos) and asymmetric dimethylarginine/ dimethylarginine dimethylaminohydrolase-1 (adma/ddah-1) signaling are key players in gastric ulcer pathogenesis. 2022-06-05 2022-06-13 Not clear
Sakkarai Mohamed Asha Parveen, Sirisha Natani, K K Sruthi, Priyanka Khilar, Ramesh Ummann. HIF-1\\xce\\xb1 and Nrf2 regulates hypoxia induced overexpression of DDAH1 through promoter activation in prostate cancer. The international journal of biochemistry & cell biology vol issue 2022 35644470 dimethylarginine dimethylaminohydrolase-1 (ddah1) is overexpressed in prostate cancer (pca) and promotes pca progression in in vivo through the adma-no pathway by degrading nitric oxide synthase (nos) inhibitors such as asymmetric dimethylarginine (adma) and monomethylamine arginine (l-nmma). 2022-06-01 2022-06-13 Not clear
Maciej Bladowski, Ewa Szahidewicz-Krupska, Jerzy Wi\\xc5\\x9bniewski, Paulina Fortuna, Justyna Chojdak-\\xc5\\x81ukasiewicz, Slawomir Budrewicz, Mariusz Fleszar, Adrian Doroszk. Changes in the Plasma and Platelet Nitric Oxide Biotransformation Metabolites during Ischemic Stroke-A Dynamic Human LC/MS Metabolomic Study. Antioxidants (Basel, Switzerland) vol 11 issue 5 2022 35624819 neurological physical examination, followed by assessment of the platelet and plasma levels of the nitric oxide synthase (nos) inhibitors, including asymmetric dimethylarginine (adma) and symmetric dimethylarginine (sdma), as well as nos substrate-l-arginine were performed dynamically three times within the first 24-h, then on the 3rd and 7th day after the stroke onset, which was compared with the healthy control. 2022-05-28 2022-06-13 Not clear
Clyde A Smith, Afshin Ebrahimpour, Lyudmila Novikova, Dominic Farina, Aaron O Bailey, William K Russell, Antrix Jain, Alexander B Saltzman, Anna Malovannaya, B V Venkataram Prasad, Liya Hu, Yohannes T Ghebr. Esomeprazole covalently interacts with the cardiovascular enzyme dimethylarginine dimethylaminohydrolase: Insights into the cardiovascular risk of proton pump inhibitors. Biochimica et biophysica acta. General subjects vol issue 2022 35472493 dimethylarginine dimethylaminohydrolase (ddah) is a cardiovascular enzyme expressed in cardiomyocytes, and other somatic cell types in one of two isotypes (ddah1 and ddah2) to metabolize asymmetric dimethylarginine (adma); a cardiovascular risk factor and competitive inhibitor of nitric oxide synthases (noss). 2022-04-26 2022-04-30 Not clear
Ebru Doneray, Kemal Utku Yazici, Ipek Percinel Yazici, Bilal Ustunda. Altered Arginine/Nitric Oxide Pathway in Children Diagnosed Attention Deficit Hyperactivity Disorder, and the Effect of 10 Weeks Methylphenidate Treatment. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology vol 20 issue 2 2022 35466106 in this study, we investigated the levels of arginine, nitric oxide (no), asymmetric dimethylarginine (adma), and adrenomedullin that are presumed to play a role in attention deficit hyperactivity disorder (adhd) etiology, and to compare the findings with healthy controls. 2022-04-25 2022-04-26 Not clear
Mingyue Zhao, Xin Liu, Yuzhu Hou, Tongtong Yang, Jiaquan Xu, Rui S. Combination of Electrochemistry and Mass Spectrometry to Study Nitric Oxide Metabolism and Its Modulation by Compound K in Breast Cancer Cells. Analytical chemistry vol issue 2022 35306816 the levels of l-arginine and asymmetric dimethylarginine (adma) and the amount of the nitric oxide (no) production have recently been linked to breast cancer and pharmaceutical effect evaluation. 2022-03-21 2022-04-14 Not clear
Juliane Hannemann, Julia Zummack, Jonas Hillig, Leonard Rendant-Gantzberg, Rainer B\\xc3\\xb6ge. Association of Variability in the DDAH1, DDAH2, AGXT2 and PRMT1 Genes with Circulating ADMA Concentration in Human Whole Blood. Journal of clinical medicine vol 11 issue 4 2022 35207213 asymmetric dimethylarginine is an endogenous inhibitor of nitric oxide synthesis and a cardiovascular risk factor. 2022-02-25 2022-02-27 Not clear
Eslam E Elhawary, Seham F Khedr, Hala M Nagy, Mohamed H El-Bradey, Mohamed R Elshanshor. Correlation of Asymmetric Dimethyl Arginine Level to Sickle Retinopathy in Children With Sickle Cell Disease. Journal of pediatric hematology/oncology vol issue 2022 35180766 asymmetric dimethyl arginine (adma) is a competitive inhibitor of nitric oxide synthetase especially in l-arginine deficiency, which is the case in sickle cell disease (scd). 2022-02-18 2022-02-23 Not clear
1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50   51   52   53   54